QINGDAO VLAND BIOTECH INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.17 CNY | +0.39% |
|
+12.38% | -33.18% |
| 2023 | Qingdao Vland Biotech INC. Reports Earnings Results for the Nine Months Ended September 30, 2023 | CI |
| 2023 | Qingdao Vland Biotech Forms Chinese JV With Germany’s Evonik | MT |
| Sales 2023 * | 1.28B 177M | Sales 2024 * | 1.44B 199M | Capitalization | 2.57B 355M |
|---|---|---|---|---|---|
| Net income 2023 * | 114M 15.73M | Net income 2024 * | 138M 19.04M | EV / Sales 2023 * | 2.01 x |
| Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 1.79 x |
| P/E ratio 2023 * |
22.4
x | P/E ratio 2024 * |
18.7
x | Employees | 1,590 |
| Yield 2023 * |
1.47% | Yield 2024 * |
1.87% | Free-Float | 32.37% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.39% | ||
| 1 week | +12.38% | ||
| Current month | -11.26% | ||
| 1 month | -6.70% | ||
| 3 months | -10.79% | ||
| 6 months | -21.04% | ||
| Current year | -33.18% |
1 week
9.50
10.21
1 month
9.0312.27
Current year
7.7015.17
1 year
7.7018.26
3 years
7.7020.52
5 years
7.7030.54
10 years
7.7030.54
| Managers | Title | Age | Since |
|---|---|---|---|
Gang Chen
CEO | Chief Executive Officer | 49 | 14-05-11 |
Pi Yuan Qiao
DFI | Director of Finance/CFO | 47 | 17-05-19 |
Bing Liang Huang
BRD | Director/Board Member | 69 | 17-05-19 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Bing Liang Huang
BRD | Director/Board Member | 69 | 17-05-19 |
De Qiang Jia
BRD | Director/Board Member | 54 | 11-05-19 |
Pi Yuan Qiao
DFI | Director of Finance/CFO | 47 | 17-05-19 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-23 | 10.17 | +0.39% | 2 219 400 |
| 24-04-23 | 10.13 | +3.16% | 2,614,360 |
| 24-04-22 | 9.82 | +1.24% | 2,500,280 |
| 24-04-19 | 9.7 | -1.22% | 2,312,040 |
| 24-04-18 | 9.82 | +1.13% | 3,281,240 |
End-of-day quote Shanghai S.E., April 23, 2024
More quotes
Qingdao Vland Biotech Co., Ltd. is a China-based company which mainly develops, produces and sells enzyme preparations, micro-ecology and animal health products. The Company's main products are enzyme preparations, micro-ecology and animal health products, such as feed enzymes, industrial enzymes, food enzymes, plant micro-ecological preparations, veterinary chemicals and veterinary drugs. The Company's products are mainly used in the washing, textile, food, feed, paper, energy and pharmaceutical industries. The Company mainly distributes its products in China and overseas markets.
Calendar
2024-04-25
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
10.13
Average target price
-
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -33.18% | 354M | |
| -1.82% | 105B | |
| +3.54% | 97.5B | |
| +1.86% | 22.19B | |
| -16.54% | 21.33B | |
| -8.49% | 18.68B | |
| -42.33% | 16.6B | |
| -21.12% | 14.52B | |
| +4.87% | 14.09B | |
| +22.38% | 10.99B |
- Stock Market
- Equities
- 603739 Stock
